Navigation Links
Somanetics Receives 510(k) Clearance From the FDA to Expand Features on Its Vital Sync Monitor

TROY, Mich., May 24 /PRNewswire-FirstCall/ -- Somanetics Corporation (Nasdaq: SMTS) announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand features on its Vital Sync™ bedside monitor and research data aggregation system.  The clearance allows for interface with a broader range of bedside devices, display of derived parameters of calculated clinical indices, and an automated events trigger to alert clinicians when patient parameters fall outside desired thresholds.

"We believe this new 510(k) supports our goal of providing monitoring technologies that help critical care clinicians simplify and manage the wealth of patient data involved in assessing and treating patients," said Bruce Barrett, Somanetics' president and chief executive officer.  "Connectivity and display of additional vital patient parameters provides clinicians with 'dash-board' patient data to help clinicians' decision making and delivery of bedside care."

Somanetics' Vital Sync system provides the clinician with a view of patient data at the point of care to help medical professionals detect deteriorating patient condition early.  The Vital Sync system allows the clinician to select specific patient data from an array of bedside devices and view the data on a single, time-synced display at the bedside.  This focuses the clinician on relevant and interrelated patient data to enhance treatment decisions and improve patient care.

"Expanded compatibility with body cooling and perfusion equipment provides a more comprehensive device package for our neonatal and pediatric intensive care customers where hypothermic and ECMO treatment are used," adds Henry Szymanski, Somanetics' senior marketing manager.  "In addition, the derived parameters and automated events features are expected to help clinicians transform individual patient metrics and events into more meaningful and actionable information."

About Somanetics

Somanetics Corporation (Nasdaq: SMTS) develops, manufactures and markets the INVOS® Cerebral/Somatic Oximeter.  The INVOS System is the only commercially-available cerebral/somatic oximeter with labeling for improved outcomes after surgery in patients above 2.5 kg.  The INVOS System is the clinical reference standard in cerebral/somatic oximetry, with a 12-year market track record, more than 750 clinical references and implementation at approximately 800 U.S. hospitals.  Somanetics also develops, manufactures and markets the Vital Sync™ System, a device that integrates data from bedside devices into a single system for enhanced patient assessment and decision making, data management and data storage.  Somanetics supports its customers through a direct U.S. sales force and clinical education team.  Covidien markets INVOS System products in Europe, Canada, the Middle East and South Africa and Edwards Lifesciences represents INVOS System products in Japan.  For more information visit

SOURCE Somanetics Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Somanetics Corporation Announces 24 Clinical Abstracts on INVOS System Presented at Annual Pediatric Academic Societies National Conference
2. Somanetics Corporation To Release First Quarter 2010 Financial Results and Host Conference Call March 17, 2010
3. Somanetics Corporation to Release Fourth Quarter and Fiscal 2009 Financial Results and Host Conference Call January 21, 2010
4. Somanetics Acquires Exclusive Sublicense to Cerebral Autoregulation Monitoring Technology Developed at The Johns Hopkins University
5. LensAR Laser System(TM) Receives FDA Clearance for Use in Cataract Surgery
6. China Sky One Medicals CEO Receives Award For "Leadership Excellence In Innovation"
7. Solta Medical Receives Provectus Innovation Award at MDB Capital Groups Bright Lights Intellectual Property Conference
8. DNA Medicine Institute Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research
9. ViaCyte, Inc., Receives Three Additional U.S. Patents, Supporting its Development of a Stem Cell Derived Treatment for Diabetes
10. VetCentric Receives Vet-VIPPS Certification from NABP
11. Mylan Receives Approval for Generic Version of Zyban(R)
Post Your Comments:
(Date:11/26/2015)... 26, 2015 --> ... approach blends immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer. ... blends immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer. ... blends immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer. ... found that immunotherapy can be efficiently combined with photodynamic ...
(Date:11/26/2015)... SAN FRANCISCO , November 26, 2015 ... 1.82 billion by 2022, according to a new report by ... as Chronic Kidney Disease (CKD) which demands kidney transplantation is ... convenient and cost effective substitute for organ transplantation. --> ... 1.82 billion by 2022, according to a new report by ...
(Date:11/26/2015)... November 26, 2015 ... the "2016 Future Horizons and Growth ... Testing Market: Supplier Shares, Country Segment Forecasts, ... their offering. --> ) ... "2016 Future Horizons and Growth Strategies in ...
Breaking Medicine Technology:
(Date:11/27/2015)... Los Angeles, CA (PRWEB) , ... November 27, 2015 , ... ... new study carried out by the University of Toronto and the University of British ... number of hospitalizations for head injuries. The article explains that part of the reason ...
(Date:11/27/2015)... ... 2015 , ... "When I was traveling, I was very ... "Many people catch diseases simply from sitting on such dirty toilet seats. I ... germs." , He developed the patent-pending QUDRATECS to eliminate the need to sit ...
(Date:11/27/2015)... ... 27, 2015 , ... Consistent with the Radiology Business ... Better Radiology Marketing Programs meeting will showcase some of the best 2015 ... Caesars Palace in Las Vegas with a pre-conference session on a collaborative approach ...
(Date:11/27/2015)... , ... November 27, 2015 , ... CBD College ... of Allied Health Education Programs (CAAHEP) awarded accreditation to its Diagnostic Medical Sonography program. ... accredited colleges, as only one of twelve colleges and universities in the state of ...
(Date:11/26/2015)... ... November 26, 2015 , ... Patients at Serenity Point ... come together on Thanksgiving Day to share the things that they are most ... Serenity Point YouTube channel, patients displayed what they wrote on index cards, describing ...
Breaking Medicine News(10 mins):